Clinical Trial Update: ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study

View source ↗

Summary

The ADVANCE ASO Amplatzer Atrial Septal Occluder Post Market Surveillance Study has been terminated. The snippet provides no trial results or stated reasons for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Septal Defect Secundum Type

Drugs mentioned

• Amplatzer Atrial Septal Occluder (Atrial Septal Occluder)

Snippet

Sponsor: Abbott Medical Devices | Conditions: Atrial Septal Defect Secundum | Status: TERMINATED